2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4353):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-45219
    ((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
    		98.90%
    ((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate (Uridine,2',3'-o-(1-methylethylidene)-,4-oxidechemicalbook,5'-(2-methylpropanoate)) is a drug intermediate for synthesis of various active compounds.
    ((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
  • HY-W249042
    4,5,6,7-Tetrahydrobenzo[d]isoxazol-5-amine hydrochloride
    		99.97%
    4,5,6,7-Tetrahydrobenzo[d]isoxazol-5-amine hydrochloride is a drug intermediate for synthesis of various active compounds.
    4,5,6,7-Tetrahydrobenzo[d]isoxazol-5-amine hydrochloride
  • HY-22225
    1-(4-Chloro-2-hydroxyphenyl)ethan-1-one
    		99.0%
    1-(4-Chloro-2-hydroxyphenyl)ethan-1-one is a drug intermediate for synthesis of various active compounds.
    1-(4-Chloro-2-hydroxyphenyl)ethan-1-one
  • HY-42451
    2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxaldehyde
    2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxaldehyde is a drug intermediate for synthesis of various active compounds.
    2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxaldehyde
  • HY-W010554
    1,4-Cyclohexanedione
    		99.98%
    1,4-Cyclohexanedione is a drug intermediate. 1,4-Cyclohexanedione is an accepted substrate of EryKR1 domain which takes on a certain biocatalyst activity and stereospecificity.
    1,4-Cyclohexanedione
  • HY-47067
    5-Ethoxypyrrolidin-2-one
    		98.89%
    5-Ethoxypyrrolidin-2-one is a drug intermediate for synthesis of various active compounds.
    5-Ethoxypyrrolidin-2-one
  • HY-Y0102
    Thiosalicylic acid
    		99.28%
    Thiosalicylic acid (2-Mercaptobenzoic acid) is an organosulfur compound bearing both sulfhydryl and carboxyl functional groups. Thiosalicylic acid acts as a desulfurizing agent. Thiosalicylic acid also serves as a ligand to synthesize azosulfonamide derivatives with antibacterial and antifungal activities, as well as their Fe3+, Cu2+ and Hg2+ chelates.
    Thiosalicylic acid
  • HY-30062
    6,7-Dimethoxy-2-tetralone
    		98.05%
    6,7-Dimethoxy-2-tetralone is a drug intermediate for synthesis of various active compounds.
    6,7-Dimethoxy-2-tetralone
  • HY-109056
    Elsulfavirine
    		99.90%
    Elsulfavirine (R-1206) is an orally active human carbonic anhydrase (carbonic anhydrase, CA) inhibitor and an allosteric inhibitor of HIV-1 non-nucleoside reverse transcriptase (NNRT). Elsulfavirine also targets and blocks the interaction between adenylosuccinate lyase (ADSL) and insulin-induced gene proteins INSIG1/2, blocks SREBP-1-mediated de novo lipid synthesis, and inhibits the proliferation of liver cancer cells. The combination of Elsulfavirine and Lenvatinib (HY-10981) produces a synergistic anti-tumor effect. Elsulfavirine is converted into the active metabolite VM1500A in vivo, blocks the DNA polymerase activity of reverse transcriptase, and inhibits HIV-1 replication. Elsulfavirine exhibits a Ki of 1960 nM-52400 nM against human carbonic anhydrase isoforms including I, VII, VI, VA, VB, IX, XIII, XIV. Elsulfavirine is used in studies related to HIV-1 infection and liver cancer.
    Elsulfavirine
  • HY-W025438
    5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine
    		98.03%
    5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine is a 2'-O-methyluridine derivative bearing a 5'-O-(4,4'-dimethoxytrityl) protecting group.5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine serves as a starting material for synthesis of a conformationally rigid cyclic uridylic acid derivative.
    5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine
  • HY-W015575
    2-Chlorobenzimidazole
    		99.54%
    2-Chlorobenzimidazole is a pharmaceutical intermediate used in the synthesis of a series of derivatives with anti-human cytomegalovirus (HCMV) activity. 2-Chlorobenzimidazole can be used to form metal complexes (cobalt, copper, and zinc), with zinc complexes exhibiting significant anticancer activity.
    2-Chlorobenzimidazole
  • HY-69055
    7-Bromoisoquinoline
    		99.98%
    7-Bromoisoquinoline is a brominated isoquinoline and synthetic precursor that constructs the isoquinoline functional group at the C17 position of target molecules. 7-Bromoisoquinoline serves as a key synthetic intermediate for the synthesis of cortistatin A-derived anti-angiogenic steroidal analogs (e.g., 7-tributylstannyl isoquinoline). 7-Bromoisoquinoline.
    7-Bromoisoquinoline
  • HY-N0137A
    (R)-Tetrahydropapaverine hydrochloride
    		99.96%
    (R)-Tetrahydropapaverine hydrochloride is the isomer of Tetrahydropapaverine hydrochloride (HY-N0137), and can be used as an experimental control. Tetrahydropapaverine hydrochloride is one of the Tetrahydroisoquinolines. Tetrahydropapaverine hydrochloride has neurotoxic effects on dopamine neurons.
    (R)-Tetrahydropapaverine hydrochloride
  • HY-50097
    3-Bromo-2-methylaniline
    		99.81%
    3-Bromo-2-methylaniline is an aromatic amine compound and aniline derivative that serves as a starting material and synthetic precursor. 3-Bromo-2-methylaniline acts as a starting material for the synthesis of 4-bromo-1H-indazole and racemic 3,9-dibromo-4,10-dimethyl-6H,12H-5,11-methanodibenzodiazocine. It also serves as a precursor for the regioselective bromination and subsequent deamination to synthesize 1,2-dibromo-3-methylbenzene.
    3-Bromo-2-methylaniline
  • HY-W041194
    Tropic acid
    		99.81%
    Tropic acid (DL-Tropic acid) is an active small molecule that can be used as the pharmaceutical intermediate.
    Tropic acid
  • HY-76366
    (S)-N-Boc-3-hydroxypyrrolidine
    		99.98%
    (S)-N-Boc-3-hydroxypyrrolidine is a pharmaceutical intermediate that can be used for the synthesis of other compounds.
    (S)-N-Boc-3-hydroxypyrrolidine
  • HY-41832
    4,6-Dichloro-2-(methylthio)pyrimidine
    		99.32%
    4,6-Dichloro-2-(methylthio)pyrimidine is an intermediate. 4,6-Dichloro-2-(methylthio)pyrimidine can be used to synthesize Kras modulators. 4,6-Dichloro-2-(methylthio)pyrimidine can be used in cancer research.
    4,6-Dichloro-2-(methylthio)pyrimidine
  • HY-W100681
    2'-Hydroxy-5'-methylacetophenone
    		99.97%
    2'-Hydroxy-5'-methylacetophenone belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
    2'-Hydroxy-5'-methylacetophenone
  • HY-W016456
    5-Bromopentanoic acid
    		98.0%
    5-Bromopentanoic acid can be used for the synthesis of inhibitors for aminoglycoside resistant bacteria.
    5-Bromopentanoic acid
  • HY-113949
    Methyl 2,3-O-Isopropylidene-β-D-ribofuranoside
    Methyl 2,3-O-Isopropylidene-β-D-ribofuranoside is a furanose derivative. Methyl 2,3-O-Isopropylidene-β-D-ribofuranoside serves as an important intermediate for the synthesis of compounds such as arsenic-containing ribosides.
    Methyl 2,3-O-Isopropylidene-β-D-ribofuranoside